At 4 weeks post-TAC, mRNA expression levels of HF markers, brain natriuretic peptide (Nppb) and β-myosin heavy chain (β-MHC), were significantly lower in NC114-treated TAC mice than in vehicle-treated TAC mice (Fig. 1i,j). Here, NPPB is linked to persistent truncus arteriosus.